Table 3.
Group | Dosage (g/kg) | Thymus weight / Mouse weight (mg/g) | Spleen weight / Mouse weight (mg/g) | Liver weight / Mouse weight (mg/g) | Tumour Inhibition (%) |
---|---|---|---|---|---|
Control group |
0 |
3.3 ± 0.5 |
3.1 ± 0.4 |
39.9 ± 2.8 |
0 |
Model group |
0 |
2.8 ± 0.9 |
3.6 ± 0.4 |
40.1 ± 2.9 |
0 |
CY |
0.02 |
2.6 ± 0.3 |
2.9 ± 0.4 |
44.3 ± 3.0 |
50.88 |
ASMq low |
2 |
3.6 ± 0.4# |
4.0 ± 0.5*# |
49.4 ± 6.0*# |
43.43 |
ASMq medium |
4 |
3.0 ± 0.7 |
4.2 ± 1.0*# |
46.8 ± 13.2 |
64.26 |
ASMq high | 8 | 3.5 ± 0/7# | 3.5 ± 0.3*# | 40.8 ± 4.4 | 49.05 |
* different from the tumour control group, *p<0.05;
# different from the CY group, #p<0.05.
CY: cyclophosphamide.
ASMq: abnormal Savda Munziq traditional Uyghur medicine.